January 31, 2011

Anticipating regulatory approval, MAP Pharmaceuticals and Allergan will collaborate to promote a drug for treating acute migraine to physicians.

March 2, 2010

Bristol-Myers Squibb is buying most of the rights to an investigational pain drug for $40...